Karius et al
Other reported or anticipated side effects based on Phase 2 data and the known pharmacology of the drug class include: Injection site reactions redness, bruising, or mild discomfort at the site of subcutaneous injection Fatigue commonly associated with caloric restriction and rapid weight loss Headache reported with GLP-1 receptor agonists as a class Increased heart rate (tachycardia) a known class effect of GLP-1 receptor agonists
The vitamins contained contribute to normal energy metabolism, nervous system function, maintenance of psychological state, reduction of fatigue, and immune system activity
GLP-1 Injections are used to help individuals with obesity or overweight manage their weight by affecting hunger, satiety, and insulin production, leading to a reduction in food intake and improved metabolic control
Consequently, this medication induces a delay in gastric emptying, promoting a prolonged feeling of fullness